Trend of Clinical Outcome and Surrogate Markers During ... - J-Stage

2 downloads 8 Views 826KB Size Report
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BNP, B-type natriuretic peptide; BUN, blood urea nitrogen;. CABG, coronary ...
ORIGINAL ARTICLE

Circulation Journal Official Journal of the Japanese Circulation Society http://www. j-circ.or.jp

Heart Failure

Trend of Clinical Outcome and Surrogate Markers During Titration of β-Blocker in Heart Failure Patients With Reduced Ejection Fraction – Relevance of Achieved Heart Rate and β-Blocker Dose – Naoko Kato, PhD; Koichiro Kinugawa, MD, PhD; Teruhiko Imamura, MD; Hironori Muraoka, MD; Shun Minatsuki, MD; Toshiro Inaba, MD; Hisataka Maki, MD; Taro Shiga, MD, PhD; Masaru Hatano, MD; Atsushi Yao, MD, PhD; Issei Komuro, MD, PhD; Ryozo Nagai, MD, PhD

Background:  The aim of this study was to examine trends of clinical outcome and to clarify surrogate markers when titrating β-blocker in heart failure patients with reduced left ventricular ejection fraction (HFrEF, LVEF